Skip Navigation

European Journal of Heart Failure 2005 7(4):542-551; doi:10.1016/j.ejheart.2004.07.005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Valle, R.
Right arrow Articles by Milani, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valle, R.
Right arrow Articles by Milani, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure

Roberto Vallea,*, Nadia Aspromonteb, Sabrina Barroa, Cristina Canalia, Emanuele Carbonieric, Vincenzo Cecib, Maura Chinellatod, Giovanni Galloe, Prospero Giovinazzoa, Roberto Riccib and Loredano Milania

a Heart Failure Unit, Cardiology Department, Ospedale Civile Via Sauro, 30027, San Dona' di Piave, Italy
b Heart Failure Unit, Cardiology Department Ospedale Santo Spirito, Roma, Italy
c Heart Failure Unit, Cardiology Department, Ospedale Civile San Bonifacio, Italy
d Basic Health Services District no. 1 San Doná di Piave, Italy
e Don Moschetta Nursing Home Caorle, Italy

* Corresponding author. Tel.: +39 421 227537; Fax: +39 421 227521. E-mail address: robertovalle{at}libero.it


   Abstract

Background: Little is known about the prevalence of heart failure among very old people, although hospitalisation rates for chronic heart failure are very high. Recently, brain natriuretic peptides have emerged as important diagnostic and prognostic serum markers for congestive heart failure.

Aims: The main purpose of our study was to determine whether there is a cut-off for NT-proBNP for detecting the echocardiographic features of left ventricular systolic and/or diastolic dysfunction and clinical heart failure among old people living in nursing homes. Secondarily, we investigated the medium-term prognostic power of the neurohormone levels.

Methods: We screened 101 old people (80% females, aged 84±9 years) from two nursing homes. We prospectively evaluated whether we could effectively stratify patients using a combination of (1) restrictive clinical criteria, (2) NT-proBNP measurements (Elecsys System, Roche Diagnostics) and (3) echocardiography for all patients.

Results: Forty-two percent of the subjects had left ventricular dysfunction: 11% systolic, 23% diastolic and 8% both systolic and diastolic. The mean NT-proBNP concentration was 2806±7028 pg/ml in the 42 patients with left ventricular systolic and/or diastolic dysfunction, compared with 365±456 pg/ml in the 59 patients with normal left ventricular function (p<0.01, Z=–4.8 Mann–Whitney U test). The neurohormone proved to be a good predictor of events within 6 months [area under the receiver-operated curve (ROC)=0.79].

Conclusions: Blood NT-proBNP concentrations can play an important role in stratifying old people into left ventricular dysfunction risk groups. The neurohormone is an independent marker for death or admission for heart failure in the medium term.

Key Words: Heart failure • Brain natriuretic peptides • Nursing homes

Received February 28, 2004; Revised May 28, 2004; Accepted July 13, 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Age AgeingHome page
B. Vaes, W. de Ruijter, J. Gussekloo, and J. Degryse
The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review
Age Ageing, November 1, 2009; 38(6): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. A. Whalley, S. P. Wright, A. Pearl, G. D. Gamble, H. J. Walsh, M. Richards, and R. N. Doughty
Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community
Eur. Heart J., February 2, 2008; 29(4): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. C. M. Corteville, K. Bibbins-Domingo, A. H. B. Wu, S. Ali, N. B. Schiller, and M. A. Whooley
N-Terminal Pro-B-Type Natriuretic Peptide as a Diagnostic Test for Ventricular Dysfunction in Patients With Coronary Disease: Data From the Heart and Soul Study
Arch Intern Med, March 12, 2007; 167(5): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Aspromonte, V. Ceci, A. Chiera, C. Coletta, A. D'Eri, M. Feola, P. Giovinazzo, L. Milani, F. Noventa, A. B. Scardovi, et al.
Rapid Brain Natriuretic Peptide Test and Doppler Echocardiography for Early Diagnosis of Mild Heart Failure
Clin. Chem., September 1, 2006; 52(9): 1802 - 1808.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.